Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer

Author： Garcia Agustin  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.5, Iss.1, 2005-03, pp. : 49-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

By Paccagnella A.   Favaretto A.   Oniga F.   Barbieri F.   Ceresoli G.   Torri W.   Villa E.   Verusio C.   Cetto G.L.   Santo A.   De Pangher V.   Artioli F.   Cacciani G.C.   Parodi G.   Soresi F.   Ghi M.G.   Morabito A.   Biason R.   Giusto M.   Mosconi P.   Chiarion Sileni V.   GSTPV Gruppo di Studio Tumori Polmonari del Veneto  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 83-91

Elsevier

Access to resources Recommend Favorite

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

By                                    

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2137-2142

Spandidos Publications

Access to resources Recommend Favorite

Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer

By Campos Susana   Berlin Suzanne   Parker Leroy   Chen Wendy   Bunnell Craig   Atkinson Tina   Lee Julie   Matulonis Ursula   Hirsch Michelle   Harris Lyndsay   Krasner Carolyn  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 390-398

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1472-1483

John Wiley & Sons Inc

Access to resources Recommend Favorite